Name | BYURO PEREVODOV MEDIFARM, OOO |
|---|
INN | 9715267369 |
|---|
KPP | 771501001 |
|---|
OGRN | 1167746686722 |
|---|
OKPO | 03627292 |
|---|
Address | 127427, G.moskva, ul. Bol'shaya Marfinskaya, d. D. 1, of. KV. 5 |
|---|
Phone | +7 (929) 654-99-34 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 74.30 | Core activity | Translation and interpretation activities |
Registration date | 21.07.2016 |
|---|
|
BYURO PEREVODOV MEDIFARM, OOO (Moscow; INN 9715267369) was registered on 21 Jul 2016. The company's authorized capital as of July 1, 2012 was 10000 rub. Principal activities of BYURO PEREVODOV MEDIFARM, OOO: translation and interpretation activities (74.30). |
Economic indicators2024
Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO dropped in 2024 by 3.03% to 50.58 million RUB from 52.17 million RUB over the same period in 2023, the company informed. Revenue remained in the accounting period at the same level and made up 56.94 million RUB compared to 57.01 million RUB 57.01 million RUB. 2023
Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO grew over 2023 by 40.28% to 52.17 million RUB from 37.19 million RUB over 2022, the company informed. Revenue increased in the accounting period by 39.63% to 57.01 million RUB from 40.83 million RUB over 2022. 2022
Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO grew over 2022 by 13.44% to 37.19 million RUB from 32.78 million RUB over 2021, the company informed. Revenue increased in the accounting period by 13.22% to 40.83 million RUB from 36.06 million RUB over 2021. 2021
Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO dropped in 2021 by 15.64% to 32.78 million RUB from 38.86 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 14.00% to 36.06 million RUB from 41.94 million RUB in 2020. 2020
Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO grew over 2020 1.91 times to 38.86 million RUB from 20.34 million RUB over 2019, the company informed. Revenue increased in the accounting period 1.89 times to 41.94 million RUB from 22.15 million RUB over 2019. 2019
Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO over 2019 was the same as in 2018 reaching 20.34 million RUB, the company informed. Revenue decreased in the accounting period by 0.69% to 22.15 million RUB from 22.30 million RUB in 2018. 2018
Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO grew over 2018 1.76 times to 20.35 million RUB from 11.59 million RUB over 2017, the company informed. Revenue increased in the accounting period 1.74 times to 22.30 million RUB from 12.82 million RUB over 2017; cost of goods sold grew by 46.95% to 770.00 thousand RUB from 524.00 thousand RUB; sales profit went up 1.75 times to 21.53 million RUB from 12.30 million RUB. 2017
Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO grew over 2017 3.54 times to 11.59 million RUB from 3.28 million RUB over 2016, the company informed. Revenue increased in the accounting period 3.56 times to 12.82 million RUB from 3.60 million RUB over 2016; cost of goods sold grew 4.48 times to 524.00 thousand RUB from 117.00 thousand RUB; sales profit went up 3.53 times to 12.30 million RUB from 3.48 million RUB. 2016
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|